WEDNESDAY, Nov. 19, 2025 (HealthDay News) -- Sequential screening for heterozygous familial hypercholesterolemia (FH) in childhood or early adulthood can be effective but is not cost-effective ...
The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback